Teva Pharmaceutical Industries | TEVA - Ebitda

Stock Price
9,270.00
Daily Change
71.00 0.77%
Monthly
-0.18%
Yearly
71.70%
Q2 Forecast
8,997.46

Teva Pharmaceutical Industries reported $1.64B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Aspen Pharmacare ZAR 6.06B 867M Jun/2024
Cipla INR 12.55B 6.4B Dec/2025
Dr.Reddys Laboratories INR 20.89B 117M Dec/2025
Guangzhou Baiy CNY 961.82M 1.37B Jun/2025
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Kalbe Farma IDR 1.3T 18.7B Jun/2025
Richter Gedeon HUF 84.16B 8.44B Dec/2024
Sh Fosun Pharma CNY 1.69B 17.13M Jun/2025
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025